PRTK Annual Total Expenses
$197.00 M
+$34.92 M+21.54%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual total expenses is $197.00 million, with the most recent change of +$34.92 million (+21.54%) on December 31, 2022. During the last 3 years, it has risen by +$64.82 million (+49.04%).PRTK Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly Total Expenses
$47.47 M
+$2.46 M+5.47%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly total expenses is $47.47 million, with the most recent change of +$2.46 million (+5.47%) on June 30, 2023. Over the past year, it has increased by +$6.75 million (+16.58%).PRTK Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.5% | +16.6% |
| 3 y3 years | +49.0% | +73.7% |
| 5 y5 years | +103.0% | +71.3% |
PRTK Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -37.1% |
Paratek Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $47.47 M(+5.5%) |
| Mar 2023 | - | $45.01 M(-40.4%) |
| Dec 2022 | $197.00 M(+21.5%) | $75.46 M(+70.2%) |
| Sept 2022 | - | $44.34 M(+8.9%) |
| June 2022 | - | $40.72 M(+11.6%) |
| Mar 2022 | - | $36.48 M(-35.5%) |
| Dec 2021 | $162.08 M(+36.2%) | $56.58 M(+61.0%) |
| Sept 2021 | - | $35.15 M(-14.9%) |
| June 2021 | - | $41.32 M(+42.3%) |
| Mar 2021 | - | $29.04 M(-10.5%) |
| Dec 2020 | $119.02 M(-10.0%) | $32.45 M(+17.0%) |
| Sept 2020 | - | $27.74 M(+1.5%) |
| June 2020 | - | $27.34 M(-13.2%) |
| Mar 2020 | - | $31.50 M(-2.0%) |
| Dec 2019 | $132.17 M(+9.1%) | $32.15 M(-2.4%) |
| Sept 2019 | - | $32.94 M(+2.4%) |
| June 2019 | - | $32.17 M(-7.9%) |
| Mar 2019 | - | $34.91 M(-5.8%) |
| Dec 2018 | $121.17 M(+24.9%) | $37.06 M(+25.0%) |
| Sept 2018 | - | $29.65 M(+7.0%) |
| June 2018 | - | $27.71 M(+3.7%) |
| Mar 2018 | - | $26.74 M(+3.3%) |
| Dec 2017 | $97.04 M(-11.7%) | $25.89 M(+27.3%) |
| Sept 2017 | - | $20.33 M(-14.6%) |
| June 2017 | - | $23.80 M(-11.9%) |
| Mar 2017 | - | $27.02 M(+3.1%) |
| Dec 2016 | $109.86 M(+55.3%) | $26.21 M(+12.6%) |
| Sept 2016 | - | $23.28 M(-21.7%) |
| June 2016 | - | $29.74 M(-2.9%) |
| Mar 2016 | - | $30.63 M(+46.9%) |
| Dec 2015 | $70.75 M(+551.4%) | $20.85 M(-11.7%) |
| Sept 2015 | - | $23.61 M(+54.5%) |
| June 2015 | - | $15.28 M(+38.7%) |
| Mar 2015 | - | $11.01 M(<-9900.0%) |
| Dec 2014 | $10.86 M | -$55.00 K(-101.4%) |
| Sept 2014 | - | $4.05 M(+10.5%) |
| June 2014 | - | $3.66 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $3.20 M(-45.1%) |
| Dec 2013 | $26.16 M(+14.3%) | $5.83 M(+13.2%) |
| Sept 2013 | - | $5.15 M(+22.4%) |
| June 2013 | - | $4.21 M(-61.6%) |
| Mar 2013 | - | $10.96 M(+65.7%) |
| Dec 2012 | $22.88 M(-2.5%) | $6.61 M(+19.4%) |
| Sept 2012 | - | $5.54 M(-0.9%) |
| June 2012 | - | $5.59 M(+8.7%) |
| Mar 2012 | - | $5.14 M(-31.4%) |
| Dec 2011 | $23.46 M(+8.0%) | $7.49 M(+34.1%) |
| Sept 2011 | - | $5.59 M(+4.5%) |
| June 2011 | - | $5.34 M(+6.2%) |
| Mar 2011 | - | $5.04 M(-11.9%) |
| Dec 2010 | $21.72 M(-13.3%) | $5.71 M(-2.7%) |
| Sept 2010 | - | $5.87 M(+13.4%) |
| June 2010 | - | $5.18 M(+4.3%) |
| Mar 2010 | - | $4.96 M(-7.6%) |
| Dec 2009 | $25.05 M(+36.9%) | $5.38 M(-10.0%) |
| Sept 2009 | - | $5.97 M(-17.8%) |
| June 2009 | - | $7.27 M(+12.9%) |
| Mar 2009 | - | $6.44 M(-216.6%) |
| Dec 2008 | $18.30 M(-65.7%) | -$5.52 M(-173.2%) |
| Sept 2008 | - | $7.54 M(+2.9%) |
| June 2008 | - | $7.33 M(-18.0%) |
| Mar 2008 | - | $8.95 M(-24.8%) |
| Dec 2007 | $53.33 M(+61.1%) | $11.89 M(-9.8%) |
| Sept 2007 | - | $13.19 M(-21.6%) |
| June 2007 | - | $16.83 M(+47.3%) |
| Mar 2007 | - | $11.43 M(+31.0%) |
| Dec 2006 | $33.12 M(+32.9%) | $8.72 M(+10.2%) |
| Sept 2006 | - | $7.92 M(-2.7%) |
| June 2006 | - | $8.13 M(-2.5%) |
| Mar 2006 | - | $8.34 M |
| Dec 2005 | $24.92 M(+25.2%) | - |
| Dec 2004 | $19.90 M(+218.4%) | - |
| Dec 2002 | $6.25 M(+279.6%) | - |
| Dec 2001 | $1.65 M | - |
FAQ
- What is Paratek Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual total expenses year-on-year change?
- What is Paratek Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly total expenses year-on-year change?
What is Paratek Pharmaceuticals annual total expenses?
The current annual total expenses of PRTK is $197.00 M
What is the all time high annual total expenses for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual total expenses is $197.00 M
What is Paratek Pharmaceuticals annual total expenses year-on-year change?
Over the past year, PRTK annual total expenses has changed by +$34.92 M (+21.54%)
What is Paratek Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of PRTK is $47.47 M
What is the all time high quarterly total expenses for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly total expenses is $75.46 M
What is Paratek Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, PRTK quarterly total expenses has changed by +$6.75 M (+16.58%)